RE:Paradigm recently said this.There must be an echo in here lol
- deep pocketed PE Firm identified as buyer of Baxter/Vantive - CHECK !
- trigger pulled on first key acquisition , due diligence period - CHECK!
- secondary acquisition by PE acknowledged as something between: a possibility and a likely outcome - CHECK!
Next up ( in no particular order)
- PE opens up secondary negotiations with other Vantive LT partners
- Tigris Trial completion
- 30 day wait ( 28-day mortality)
- Top line data release
- acquisition
- FDA final decision
The number of possible SP catalysts are multiplying like rabbits
MM